T Cell Receptor CDR3 Sequence but Not Recognition Characteristics Distinguish Autoreactive Effector and Foxp3+ Regulatory T Cells

Immunity

Volumn 31, Issue 6, 2009, Pages 909-920

  Liu, Xin ^a,b   Nguyen, Phuong ^a   Liu, Wei ^a   Cheng, Cheng ^a   Steeves, Meredith ^a   Obenauer, John C ^a   Ma, Jing ^a   Geiger, Terrence L ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

CELLIMMUNO; MOLIMMUNO

Indexed keywords

AUTOANTIGEN; CD3 ANTIGEN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; TRANSCRIPTION FACTOR FOXP3;

ACIDITY; ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CELL LINEAGE; CONTROLLED STUDY; EFFECTOR CELL; LYMPHOCYTE SUBPOPULATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; ONTOGENY; PLASTICITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FORKHEAD TRANSCRIPTION FACTORS; GLYCOPROTEINS; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, REGULATORY;

EID: 71749113619     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2009.09.023     Document Type: Article

References (55)

1. Aifantis I., Mandal M., Sawai K., Ferrando A., and Vilimas T. Regulation of T-cell progenitor survival and cell-cycle entry by the pre-T-cell receptor. Immunol. Rev. 209 (2006) 159-169
2. Alli R., Nguyen P., and Geiger T.L. Retrogenic modeling of experimental allergic encephalomyelitis associates T cell frequency but not TCR functional affinity with pathogenicity. J. Immunol. 181 (2008) 136-145
3. Andersson J., Stefanova I., Stephens G.L., and Shevach E.M. CD4+CD25+ regulatory T cells are activated in vivo by recognition of self. Int. Immunol. 19 (2007) 557-566
4. Bailey S.L., Schreiner B., McMahon E.J., and Miller S.D. CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. Nat. Immunol. 8 (2007) 172-180
5. Bautista J.L., Lio C.W., Lathrop S.K., Forbush K., Liang Y., Luo J., Rudensky A.Y., and Hsieh C.S. Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat. Immunol. 10 (2009) 610-617
6. Ben-Nun A., Kerlero de Rosbo N., Kaushansky N., Eisenstein M., Cohen L., Kaye J.F., and Mendel I. Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): Prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b mice. Eur. J. Immunol. 36 (2006) 478-493
7. Borowski C., Li X., Aifantis I., Gounari F., and von Boehmer H. Pre-TCRalpha and TCRalpha are not interchangeable partners of TCRbeta during T lymphocyte development. J. Exp. Med. 199 (2004) 607-615
8. Coombes J.L., Siddiqui K.R., Arancibia-Cárcamo C.V., Hall J., Sun C.M., Belkaid Y., and Powrie F. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204 (2007) 1757-1764
9. Delarasse C., Daubas P., Mars L.T., Vizler C., Litzenburger T., Iglesias A., Bauer J., Della Gaspera B., Schubart A., Decker L., et al. Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J. Clin. Invest. 112 (2003) 544-553
10. Fontenot J.D., and Rudensky A.Y. A well adapted regulatory contrivance: Regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6 (2005) 331-337
11. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., and Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005) 329-341
12. Grajewski R.S., Silver P.B., Agarwal R.K., Su S.B., Chan C.C., Liou G.I., and Caspi R.R. Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity. J. Exp. Med. 203 (2006) 851-856
13. Holst J., Szymczak-Workman A.L., Vignali K.M., Burton A.R., Workman C.J., and Vignali D.A. Generation of T-cell receptor retrogenic mice. Nat. Protoc. 1 (2006) 406-417
14. Hori S., Haury M., Coutinho A., and Demengeot J. Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA 99 (2002) 8213-8218
15. Horwitz D.A., Zheng S.G., and Gray J.D. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol. 29 (2008) 429-435
16. Hsieh C.S., Liang Y., Tyznik A.J., Self S.G., Liggitt D., and Rudensky A.Y. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21 (2004) 267-277
17. Hsieh C.S., Zheng Y., Liang Y., Fontenot J.D., and Rudensky A.Y. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat. Immunol. 7 (2006) 401-410
18. Huang C.Y., and Kanagawa O. Impact of early expression of TCR alpha chain on thymocyte development. Eur. J. Immunol. 34 (2004) 1532-1541
19. Huter E.N., Stummvoll G.H., DiPaolo R.J., Glass D.D., and Shevach E.M. Cutting edge: Antigen-specific TGF beta-induced regulatory T cells suppress Th17-mediated autoimmune disease. J. Immunol. 181 (2008) 8209-8213
20. Jordan M.S., Boesteanu A., Reed A.J., Petrone A.L., Holenbeck A.E., Lerman M.A., Naji A., and Caton A.J. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2 (2001) 301-306
21. Kaigh W.C., and Cheng C. Subsampling quantile estimators standard errors with applications. Commun. Stat. Theory Methods 20 (1991) 977-995
22. Kohm A.P., Carpentier P.A., Anger H.A., and Miller S.D. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169 (2002) 4712-4716
23. Korn T., Reddy J., Gao W., Bettelli E., Awasthi A., Petersen T.R., Bäckström B.T., Sobel R.A., Wucherpfennig K.W., Strom T.B., et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13 (2007) 423-431
24. Lathrop S.K., Santacruz N.A., Pham D., Luo J., and Hsieh C.S. Antigen-specific peripheral shaping of the natural regulatory T cell population. J. Exp. Med. 205 (2008) 3105-3117
25. Liang S., Alard P., Zhao Y., Parnell S., Clark S.L., and Kosiewicz M.M. Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J. Exp. Med. 201 (2005) 127-137
26. Manicassamy S., Ravindran R., Deng J., Oluoch H., Denning T.L., Kasturi S.P., Rosenthal K.M., Evavold B.D., and Pulendran B. Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat. Med. 15 (2009) 401-409
27. McGeachy M.J., Stephens L.A., and Anderton S.M. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J. Immunol. 175 (2005) 3025-3032
28. Mekala D.J., Alli R.S., and Geiger T.L. IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes. Proc. Natl. Acad. Sci. USA 102 (2005) 11817-11822
29. Mendel I., Kerlero de Rosbo N., and Ben-Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: Fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25 (1995) 1951-1959
30. Mendel Kerlero de Rosbo N., and Ben-Nun A. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: Diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice. Eur. J. Immunol. 26 (1996) 2470-2479
31. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., and Cheroutre H. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317 (2007) 256-260
32. O'Connor R.A., and Anderton S.M. Multi-faceted control of autoaggression: Foxp3+ regulatory T cells in murine models of organ-specific autoimmune disease. Cell. Immunol. 251 (2008) 8-18
33. Pacholczyk R., and Kern J. The T-cell receptor repertoire of regulatory T cells. Immunology 125 (2008) 450-458
34. Pacholczyk R., Ignatowicz H., Kraj P., and Ignatowicz L. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity 25 (2006) 249-259
35. Pacholczyk R., Kern J., Singh N., Iwashima M., Kraj P., and Ignatowicz L. Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells. Immunity 27 (2007) 493-504
36. Persons D.A., Allay J.A., Allay E.R., Smeyne R.J., Ashmun R.A., Sorrentino B.P., and Nienhuis A.W. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 90 (1997) 1777-1786
37. Petersen T.R., Bettelli E., Sidney J., Sette A., Kuchroo V., and Bäckström B.T. Characterization of MHC- and TCR-binding residues of the myelin oligodendrocyte glycoprotein 38-51 peptide. Eur. J. Immunol. 34 (2004) 165-173
38. Picca C.C., Larkin III J., Boesteanu A., Lerman M.A., Rankin A.L., and Caton A.J. Role of TCR specificity in CD4+ CD25+ regulatory T-cell selection. Immunol. Rev. 212 (2006) 74-85
39. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., Caccamo M., Oukka M., and Weiner H.L. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453 (2008) 65-71
40. Reddy J., Illes Z., Zhang X., Encinas J., Pyrdol J., Nicholson L., Sobel R.A., Wucherpfennig K.W., and Kuchroo V.K. Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 101 (2004) 15434-15439
41. Reddy J., Waldner H., Zhang X., Illes Z., Wucherpfennig K.W., Sobel R.A., and Kuchroo V.K. Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 175 (2005) 5591-5595
42. Romagnoli P., Hudrisier D., and van Meerwijk J.P. Preferential recognition of self antigens despite normal thymic deletion of CD4(+)CD25(+) regulatory T cells. J. Immunol. 168 (2002) 1644-1648
43. Selvaraj R.K., and Geiger T.L. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J. Immunol. 178 (2007) 7667-7677
44. Selvaraj R.K., and Geiger T.L. Mitigation of experimental allergic encephalomyelitis by TGF-beta induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance. J. Immunol. 180 (2008) 2830-2838
45. Sugiyama H., Gyulai R., Toichi E., Garaczi E., Shimada S., Stevens S.R., McCormick T.S., and Cooper K.D. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J. Immunol. 174 (2005) 164-173
46. Tang Q., and Bluestone J.A. Regulatory T-cell physiology and application to treat autoimmunity. Immunol. Rev. 212 (2006) 217-237
47. Tang Q., and Bluestone J.A. The Foxp3+ regulatory T cell: A jack of all trades, master of regulation. Nat. Immunol. 9 (2008) 239-244
48. Tang Q., Henriksen K.J., Bi M., Finger E.B., Szot G., Ye J., Masteller E.L., McDevitt H., Bonyhadi M., and Bluestone J.A. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199 (2004) 1455-1465
49. Viglietta V., Baecher-Allan C., Weiner H.L., and Hafler D.A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199 (2004) 971-979
50. Wong J., Mathis D., and Benoist C. TCR-based lineage tracing: No evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets. J. Exp. Med. 204 (2007) 2039-2045
51. Wong J., Obst R., Correia-Neves M., Losyev G., Mathis D., and Benoist C. Adaptation of TCR repertoires to self-peptides in regulatory and nonregulatory CD4+ T cells. J. Immunol. 178 (2007) 7032-7041
52. You S., Leforban B., Garcia C., Bach J.F., Bluestone J.A., and Chatenoud L. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. Proc. Natl. Acad. Sci. USA 104 (2007) 6335-6340
53. Yu P., Gregg R.K., Bell J.J., Ellis J.S., Divekar R., Lee H.H., Jain R., Waldner H., Hardaway J.C., Collins M., et al. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. J. Immunol. 174 (2005) 6772-6780
54. Zhang X., Koldzic D.N., Izikson L., Reddy J., Nazareno R.F., Sakaguchi S., Kuchroo V.K., and Weiner H.L. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int. Immunol. 16 (2004) 249-256
55. Zhang Y., Wang H.B., Chi L.J., and Wang W.Z. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis. Immunol. Lett. 122 (2009) 52-57